ACS Nano · 2013 · 160 citations · 26 references
EngineeringBioengineeringBiomedical EngineeringBiosensorsNanobiotechnologyNanomaterialsClinical BiosensingNanomaterial-based BiosensorsNanomedicineNanosensorsOptical BiosensorsProstate-specific Antigen TestingBiosensor Sensitivity EnhancementDiagnostic NanoprobesEarly DiagnosisGold Nanoparticle BiosensorsGold Nanoparticle DetectionNanoparticle-based ProbesNanoparticle-based SensingReal-world Application
It is still in high demand to develop extremely sensitive and accurate clinical tools for biomarkers of interest for early diagnosis and monitoring of diseases. In this report, we present a highly sensitive and compatible gold nanoparticle (AuNP)-based fluorescence-activatable probe for sensing ultralow levels of prostate-specific antigen (PSA) in patient serum samples. The limit of detection of the newly developed probe for PSA was pushed down to 0.032 pg/mL, which is more than 2 orders of magnitude lower than that of the conventional fluorescence probe. The ultrahigh sensitivity of this probe was attributed to the high loading efficiency of the dyes on AuNP surfaces and high fluorescence quenching-unquenching abilities of the dye-AuNP pairs. The efficiency and robustness of this probe were investigated in patient serum samples, demonstrating the great potential of this probe in real-world applications.
26
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran et al. · Nature · 2007 · 3.5K citations · Full text
Medicine, Cancer Biology, Oncology +15